Study Investigating the Association of NP137 With Atezolizumab-Bevacizumab Combination in First Line in Unresectable HCC
Study Investigating the Association of NP137 With Atezolizumab-Bevacizumab Combination in First Line in Unresectable HCC
Active, not recruiting · NCT05546879 · Registry updated 2026-05-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study Investigating the Association of NP137 With Atezolizumab-Bevacizumab Combination in First Line in Unresectable HCC | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Active, not recruiting | Phase 1 | 2026-05-20 | NCT05546879 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| NETRIS Pharma | 4 |
| University Hospital, Grenoble | 183 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| 12 Hôpital St Joseph | Marseille | France | 1 |
| AP-HP Beaujon | Paris | France | 1 |
| AP-HP St Antoine | Paris | France | 2 |
| CHU Angers | Angers | France | 87 |
| CHU de GRENOBLE ALPES | Grenoble | France | 1 |
| CHU Nantes | Nantes | France | 86 |
| CHU Reims | Reims | France | 24 |
| CHU Toulouse | Toulouse | France | 76 |
| Hôpital Haut Lêveque | Bordeaux | France | 1 |